Moneycontrol Be a Pro
Get App
Last Updated : Sep 30, 2019 08:49 PM IST | Source: Moneycontrol.com

3-Point Analysis | The Ranitidine impact on pharma companies

Ranitidine had a knee-jerk impact on some of the Indian pharma and API companies.

Moneycontrol News @moneycontrolcom

The US FDA  found a carcinogenic substance in some samples of acidity medicine Ranitidine.

Ranitidine had a knee-jerk impact on some of the Indian pharma and API companies. The overall ranitidine market for Indian companies is worth nearly Rs 200 crore.

Sakshi Batra does a 3-Point Analysis of why this drug is under the lens and what it could mean for pharma and API companies.

The Great Diwali Discount!
Unlock 75% more savings this festive season. Get Moneycontrol Pro for a year for Rs 289 only.
Coupon code: DIWALI. Offer valid till 10th November, 2019 .
First Published on Sep 30, 2019 08:00 pm
Loading...
Sections
Follow us on
Available On
PCI DSS Compliant
Make every wish come true
10% CashBack on Apparel
10% CashBack on Electronics
Swipe & Win iPhone 11 every hour